Nucleic Acids Research, 2000, Vol. 28, No. 2 641-647
© 2000 Oxford University Press
The 5' stem–loop regulates expression of collagen 
1(I) mRNA in mouse fibroblasts cultured in a three-dimensional matrix
Departments of Medicine and Biochemistry and Biophysics, University of North Carolina at Chapel Hill, CB 7038, Chapel Hill, NC 27599, USA
Received July 27, 1999; Revised November 2, 1999; Accepted November 18, 1999.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
The stability of collagen
1(I) mRNA is regulated by its 5' stem–loop, which binds a cytoplasmic protein in a cap-dependent manner, and its 3'-untranslated region (UTR), which binds CP. When cultured in a three-dimensional gel composed of type I collagen, mouse fibroblasts had decreased collagen 1(I) mRNA steady-state levels, which resulted from a decreased mRNA half-life. In cells cultured in gel, hybrid mouse–human collagen 1(I) mRNA with a wild-type 5' stem–loop decayed faster than the same mRNA with a mutated stem–loop. When the 5' stem–loop was placed in a heterologous mRNA, the mRNA accumulated to a lower level in cells grown in gel than in cells grown on plastic. This suggests that the 5' stem–loop down-regulates collagen 1(I) mRNA. Protein binding to the 5' stem–loop was reduced in cells grown in gel, which was associated with destabilization of the collagen 1(I) mRNA. In addition to the binding of a cytoplasmic protein, there was also a nuclear binding activity directed to the collagen 1(I) 5' stem–loop. The nuclear binding was increased in cells grown in gel, suggesting that it may negatively regulate expression of collagen 1(I) mRNA. Binding of CP, a protein involved in stabilization of collagen 1(I) mRNA, was unchanged by the culture conditions. |
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Type I collagen is the most abundant protein in mammals and is composed of two
1(I) chains and one 2(I) chain (1). Separate genes encode these polypeptides, the expression of which is coordinately regulated (2,3). The 1(I) gene is regulated at the transcriptional and post-transcriptional level in various cell types (4–10). Transcription of the 1(I) gene is driven by proximal promoter sequences, which bind several ubiquitous transcription factors (11–13). A region of 2300 or 440 nt of the promoter has been found to be sufficient for transcription of a reporter gene in transgenic mice in several studies (14–17). However, to achieve expression similar to the endogenous gene in collagen-producing tissue, the transgene had to be present in multiple copies (10–12 copies) in these animals (14). At the same time the mice had overexpression of the transgene in tissues that normally produce low levels of collagen, like liver, spleen, thymus and lungs. Clearly, the proximal promoter of the 1(I) gene cannot fully account for the regulated expression in transgenic animals. Distal DNase I hypersensitive sites were described in the 1(I) gene locus as potential binding sites for enhancer-like or locus controlling region factors, but the functional significance of these sites is not known (18).
Expression of the 1(I) gene is also regulated at the post-transcriptional level (6–10,19,20). We measured the rate of transcription of this gene in quiescent hepatic stellate cells (hscs), which produce a small amount of 1(I) mRNA, and in activated hscs, where this mRNA is expressed at a 60- to 70-fold higher level. The transcription rate was increased only 3-fold (8). However, the half-life of the 1(I) mRNA was increased ~16-fold in activated hscs compared to quiescent hscs, suggesting a predominantly post-transcriptional regulation of the 1(I) gene in this model. CP, a protein involved in stabilization of -globin mRNA (21,22) and tyrosine hydroxylase mRNA (23,24), binds to the collagen 1(I) mRNA 3'-untranslated region (UTR) in activated hscs and may be involved in its post-transcriptional regulation (8).
The 5'-UTRs of 1(I) mRNA, 2(I) mRNA and 1(III) mRNA contain an evolutionarily conserved stem–loop structure (9,25). These three mRNAs are coordinately up-regulated in fibrotic processes of various organs (3,26–29). We analyzed a regulatory role of the 5' stem–loop in the expression of reporter genes in quiescent and activated hscs (9). We found that the stem–loop prevented expression of the reporter genes in quiescent hscs but allowed expression in activated hscs. Reporter genes with a mutated stem–loop were constitutively expressed in both cell types. This inhibitory effect of the stem–loop was in part mediated by a decreased half-life of the corresponding mRNAs (9). In activated hscs, as well as in mouse fibroblasts, there are protein factors that bind the stem–loop in a cap-dependent manner. Because this binding is absent in quiescent hscs, we postulated that it is required for stabilization of collagen 1(I) mRNA (9). These studies have shown the importance of two regions of collagen 1(I) mRNA, the CP binding site in the 3'-UTR and the stem–loop in the 5'-UTR, as well as their cognate protein factors, in post-transcriptional regulation of collagen 1(I) mRNA.
Culture conditions of fibroblasts often have a pronounced effect on gene expression and cell morphology (19,20,30–34). Cells grown within or on a matrix composed of extracellular proteins extracted from Engelbreth–Swarm–Holms tumor (matrigel) or pure collagen type I gels are in a more physiological environment than cells grown on plastic. Several studies have shown that primary human fibroblasts down-regulate collagen 1(I) mRNA steady-state levels when cultured within a collagen gel matrix (19,20,32,33). This down-regulation was partly due to an increased turnover of 1(I) mRNA and was accompanied by a more elongated appearance of the cells (19,20). Similarly, activated hscs reverse to a more quiescent phenotype when cultured in matrigel (35).
In this paper we used mouse fibroblast cell lines and a matrix gel composed of collagen type I to study the role of previously identified cis-acting elements in the regulation of collagen 1(I) mRNA. We found that collagen 1(I) mRNA is destabilized in cells grown within a matrix and that its increased turnover requires the presence of the 5' stem–loop. Previously identified protein factors that bind the stem–loop are reduced in cells grown in the gel. However, a novel stem–loop binding activity was found in nuclear extracts and was increased in cells grown in the gel. We propose a complex regulation of collagen 1(I) mRNA by two differentially expressed RNA binding activities.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Cell culture
NIH 3T3 and Swiss 3T3 cells were grown in DMEM supplemented with 10% calf serum. For culture in the collagen matrix, 106 cells were suspended in 12 ml of a 1 mg/ml solution of collagen type I (Collaborative Biomedical Products) in DMEM/10% calf serum and seeded in a 100 mm plate, as described (33). The collagen gel formed before the cells had settled and within 2–3 min. For measuring mRNA half-life, actinomycin D (Sigma) was added to the medium or on the gel at 15 µg/ml. Cells were harvested from plates by scraping and from the gel by digestion of the matrix with 50 µl of 2% collagenase B (Boehringer), for 30 min at 37°C. Transient transfections were performed by the calcium phosphate method using 30 µg of DNA per 150 mm plate. Twenty-four hours after addition of the precipitate the medium was changed and after an additional 24 h the cells were pooled and seeded into a gel matrix in several plates. Adenovirus-mediated gene transfer was carried out at an MOI of 1000 and the cells were processed as above.
Plasmid constructs
Construction of the adenoviruses has been described (9). Hybrid mouse–human collagen genes were made as follows. A full-size human collagen 1(I) cDNA was obtained from ATCC (clone no. 61322). From that clone, a 2.5 kb EcoRI–BamHI fragment was subcloned into the HindIII and BamHI sites of vector pGL3 (Promega), after blunting the EcoRI and HindIII sites. Then, a 2.3 kb BamHI–BamHI fragment of ATCC 61322 was cloned into the BamHI site of the above pGL3 clone. A 330 nt BglII–XbaI fragment of the promoter and the first exon of the mouse collagen 1(I) gene, either with the wild-type sequence or with a mutation in the stem–loop, was cloned into the BglII–XbaI sites of the pGL3 clone, generating the chimeric mouse–human collagen 1(I) genes mWT/hCOLL and mMUT/hCOLL, respectively. Both of these genes contain only the first polyadenylation signal of the human collagen 1(I) gene. Riboprobes used to map expression of luciferase reporter genes and the endogenous collagen 1(I) gene have been described (9). The template for the riboprobe for mouse GAPDH was obtained from Ambion and in experiments with hybrid mouse–human genes was used after linearization with StyI. The riboprobe used to analyse the hybrid mouse–human collagen mRNA was made by subcloning a 142 nt XbaI–KpnI fragment of ATCC 61322 into the KpnI–XbaI sites of vector Bluscript SK. After linearization with SacI and transcription with T7 RNA polymerase the template gives a riboprobe of 173 nt which protects 150 nt of human collagen 1(I) mRNA. Short RNA with the sequence of the mouse collagen 1(I) 5' stem–loop or RNA with this stem–loop inverted have been described (9). These RNAs were made with or without the 7mG cap structure as described (9).
Preparation of cell extracts and electrophoretic mobility shift assay
Cytoplasmic cellular extracts were prepared as before (9). Nuclear extracts were made according to Digman (36). Mobility shift assays were performed by incubating 40 000 c.p.m. of labeled RNA probe with 60–70 µg of extract in 25 µl of 25 mM KCl, 10 mM Tris–HCl, pH 7.6, 10 mM MgCl2, 200 ng/µl tRNA, 10% glycerol. Competitor RNA was added as indicated. For mobility shift experiments with the CP probe (8), 10 µg of extract was used and different antibodies added as indicated. For experiments with nuclear extracts, 60 µg of extract was used together with 4 µg of HeLa total RNA to suppress non-specific binding. After a 20 min incubation on ice, samples were resolved on a 6% native acrylamide gel.
RNase protection assay
This assay was done as described (8,9) using 25 µg of total RNA. The riboprobe for the test gene and that for GAPDH, as an internal control, were always hybridized together. Intensities of experimental bands were quantitated by phosphorimaging and normalized to their GAPDH control bands. In experiments with hybrid mouse–human genes, the digestion mixture contained RNase ONE (1 U/ml), in addition to RNase A and RNase T1.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Primary human fibroblasts decrease their steady-state levels of collagen
1(I) mRNA when cultured in a type I collagen matrix (19,20,32,33). To see if the same result is obtained with mouse fibroblast lines, we cultured Swiss 3T3 and NIH 3T3 cells on plastic or within a gel composed of pure collagen type I. Three days after plating, the cells were analyzed for collagen 1(I) mRNA by RNase protection assays and expression was compared to the internal standard GAPDH mRNA (Fig. 1). In Swiss 3T3 cells grown in gel, collagen 1(I) mRNA was decreased to 20% of the level seen in cells grown on plastic (lanes 1 and 2). For NIH 3T3 cells this decrease was ~50% (lanes 3 and 4). Thus, mouse fibroblast lines down-regulate collagen 1(I) mRNA in a three-dimensional matrix similarly to primary fibroblasts. We have consistently observed a greater effect with Swiss 3T3 cells than with NIH 3T3 cells. Cultured in gel, both cells had an elongated shape with long cytoplasmic protrusions, as described for primary fibroblasts (not shown) (33). Contraction of the collagen gel was minimal after 3 days in culture. Based on this result, we decided to use this model to study the mechanism that decreases collagen 1(I) mRNA in more detail.
|
Decreased steady-state levels of mRNA can be a result of its decreased synthesis or increased degradation or both. Since there is some evidence that primary cells in matrix destabilize collagen
1(I) mRNA (10,19,20), we measured the half-life of endogenous 1(I) mRNA in Swiss 3T3 fibroblasts grown on plastic and in gel. Figure 2 shows the results of two independent experiments. In cells grown on plastic there was no decrease in collagen 1(I) mRNA level up to 12 h after transcription block. This is consistent with a long half-life of this mRNA in Swiss 3T3 fibroblasts, as described previously (10). However, in cells grown in gel, collagen 1(I) mRNA decayed faster, with a half-life of ~12 h. Therefore, increased turnover of collagen 1(I) mRNA is, at least in part, responsible for its lower steady-state level in the mouse cells grown within a collagen matrix.
|
We have previously described two cis-acting elements that are involved in post-transcriptional regulation of collagen
1(I) mRNA in hscs, the CP binding site in its 3'-UTR (8) and the stem–loop structure in its 5'-UTR (9). To demonstrate a role for the stem–loop in the down-regulation of collagen 1(I) mRNA in cells grown in gel, we infected Swiss 3T3 fibroblasts with adenoviruses expressing reporter genes and subsequently cultured these cells on plastic or in gel for 3 days. The reporter genes used in this experiment, WT/LUC and MUT/LUC, are driven by the SV40 promoter and contain the luciferase open reading frame and 3' flanking sequence (9) (Fig. 3A). The WT/LUC gene has the wild-type collagen 1(I) stem–loop structure in its 5'-region, while the MUT/LUC gene has a mutation of the stem–loop. Figure 3B shows a representative RNase protection analysis of the expression of these genes. This experiment was repeated three times with similar results. The WT/LUC reporter gene was expressed at a much lower level than the MUT/LUC gene (compare lanes 1 and 2 to lanes 3 and 4), as described previously (9). The WT/LUC gene was expressed at a similar level in cells grown in gel (lane 2) as in cells grown on plastic (lane 1). The MUT/LUC gene was expressed at 2- to 4-fold higher levels in cells grown in gel (lane 4) than in cells grown on plastic (lane 3). This increase probably reflects an increased activity of the viral promoter, since when we infected the cells with virus expressing ß-galactosidase under control of the CMV promoter, the ß-galactosidase activity was found to be higher in cells grown in gel than in cells grown on plastic (not shown). Clearly, the presence of the 5' stem–loop can abrogate the increase in expression in gel, and we conclude that the collagen stem–loop structure can down-regulate a heterologous mRNA in cells grown in the matrix.
|
To provide insight into the mechanism by which the stem–loop decreases steady-state levels of mRNA and to show that it has the same effect in the authentic collagen mRNA, we constructed two hybrid mouse–human collagen genes (Fig. 4A). These genes are driven by 220 nt of the mouse collagen
1(I) promoter, followed by 120 nt of mouse 5'-UTR sequence with either the wild-type or a mutated stem–loop, ligated to the full-size human collagen cDNA and its 3' flanking region (genes mWT/hCOLL and mMUT/hCOLL). These genes synthesize mRNAs with the collagen 1(I) sequence, with or without a stem–loop structure, and their expression can be distinguished from the endogenous mouse 1(I) gene by a sensitive RNase protection assay using a human-specific riboprobe. Thus, the role of the stem–loop can be analyzed in its natural RNA context. These genes were transiently transfected into NIH 3T3 cells, since the transfection efficiency into Swiss 3T3 cells was too low to allow such an analysis. After transfection, the cells were seeded into the collagen gel for 3 days and the half-life of the mRNAs was estimated (Fig. 4B). Comparison of lanes 1 and 4 shows the specificity of the RNase protection assay using a riboprobe specific for the human sequences of the transgenes. Bands representing mWT/hCOLL mRNA are present in transfected cells (COLL, lanes 1–3). There was no cross-reactivity with the endogenous mouse 1(I) mRNA in non-transfected cells (lane 4). A specific band of a slightly higher electrophoretic mobility was seen with mMUT/hCOLL mRNA using the same probe (lanes 5–7), presumably resulting from slightly extended hybridization of the probe to the mutated sequence. Again, the probe was specific for the transgene (compare lanes 5–7 to lane 8). The mWT/hCOLL mRNA was less stable, with a half-life of ~6 h (lanes 1–3), than the mMUT/hCOLL mRNA, which showed no decay after 6 h (lanes 5–7). This clearly demonstrates that the stem–loop is required for accelerated decay of collagen 1(I) mRNA in gel. In this experiment there was no correction for transfection efficiency of the two constructs, so the steady-state level of the mRNAs at time 0 may not accurately represent their accumulation. A different riboprobe for GAPDH was used in this experiment than in the experiments shown in Figures 1 and 3, which produces a shorter protected band, so that the positions of the bands appear slightly different. GAPDH mRNA is a stable RNA and showed no decay within 6 h, as described previously (8).
|
The collagen
1(I) stem–loop binds cytosolic proteins in a cap-dependent manner in activated hscs and fibroblasts (9). This binding abrogates the negative effect of the stem–loop and allows for mRNA accumulation. Therefore, we compared the stem–loop binding activity in extracts of Swiss 3T3 fibroblasts cultured on plastic and in gel by incubating the extracts with 7mG capped 5' stem–loop RNA (5'SL) or capped RNA with an inverted stem–loop (INV), which served as a control. The RNA–protein complexes were resolved on a native acrylamide gel (Fig. 5A). The specific stem–loop binding activity was detected in extracts of cells grown on plastic (lane 2), as before (9). A non-specific complex was also formed in this extract. The 5' stem–loop specific binding activity was greatly reduced in extracts of cells grown in gel (lane 3). As expected, the INV RNA bound only cap binding proteins in both extracts (lanes 5 and 6), as well as the non-specific complex from the plate extract. Formation of this non-specific complex was associated with a reduction in the fast migrating cap binding complex CBP (lane 5), so it may represent a higher order cap binding complex (37). Taking this into account, the cap binding proteins seem to be equally abundant in the two extracts, and can serve as a control for loading.
|
In our previous work we found that
CP, a protein involved in stabilization of -globin (21,22) and tyrosine hydroxylase mRNAs (24), binds to the 3'-UTR of collagen 1(I) mRNA and proposed its role in stabilization of this mRNA (8). Therefore, we performed a gel mobility shift experiment with the same extracts, but used the CP binding sequence as a probe (Fig. 5B). There was no difference in binding activity of CP in cells grown on plastic or in gel (lanes 2 and 3). The two complexes seen in this experiment probably represent alternatively spliced isoforms or different modifications of CP. Addition of polyclonal antibody specific to both isoforms of CP (22) (a kind gift of S. Liebhaber) resulted in a supershift of the complexes (lane 4, open arrow), while addition of an antibody to smooth muscle actin (SMA) had no effect (lane 5). We conclude from this experiment that culture of mouse fibroblasts in gel decreases binding activity to the collagen 5' stem–loop. This is associated with a decreased stability of this mRNA and a reduced steady-state level. No change in the binding activity of CP was observed.
After synthesis in the nucleus, some mRNAs associate with sequence-specific RNA binding proteins, which have important regulatory roles (38,39). We wanted to determine if a nuclear protein binds the collagen 5' stem–loop in a sequence-specific manner. We prepared nuclear extract from Swiss 3T3 fibroblasts grown on plastic and incubated the extract with 5'SL RNA as a probe. This 5'SL RNA probe did not contain 7mG cap as in the experiments with cytoplasmic extracts. As shown in Figure 6A, lane 2, an RNA–protein complex was formed. This complex was efficiently competed out with an excess of the same unlabeled RNA (lanes 3 and 4). It was not significantly effected by an excess of INV RNA, which served as a non-specific competitor (lanes 5 and 6). This result suggests that there is a nuclear protein which recognizes the collagen 1(I) mRNA 5' stem–loop, and that binding of this protein does not require a 7mG cap on the RNA. This feature makes it clearly distinct from the cytoplasmic stem–loop binding protein described in Figure 5 and Stefanovic et al. (9). Next, we made nuclear extracts from cells grown in gel and on plastic and compared their binding activities. The nuclear extract made from Swiss 3T3 cells grown in gel contained more of the stem–loop binding activity than the extract from cells grown on plastic (Fig. 6B, compare lanes 2 and 3). Therefore, culturing cells in the collagen matrix regulates the nuclear 5' stem–loop binding activity differently than the cytoplasmic binding activity.
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Expression of collagen
1(I) gene is a complex process involving both transcriptional and post-transcriptional mechanisms (6–10,19,20). We have previously reported the importance of post-transcriptional regulation of this gene in cells which differentiate from the quiescent phenotype (quiescent hscs) to the activated phenotype (activated hscs), as well as the importance of the 5' stem–loop structure in this process (8,9). In this paper we demonstrate a role of the 5' stem–loop in the opposite process, in cells which revert to a more quiescent phenotype after being cultured within a collagen type I matrix. A change in cell morphology upon culture within a three-dimensional matrix has been reported for primary human fibroblasts (33). This was associated with a decreased steady-state level of collagen 1(I) mRNA and its increased turnover (9,19,20). Here we show that rodent fibroblast cell lines exhibit a similar property; a morphological change to a more elongated form and a 50–80% decrease in collagen 1(I) mRNA accumulation (Fig. 1). The decreased mRNA level was due to selective destabilization of this mRNA (Fig. 2). Collagen 1(I) mRNA is a stable mRNA in rodent fibroblasts with a reported half-life ranging from 8 to >18 h, depending on cell type, culture conditions and method of measurement (6,10,40,41). We reported a half-life of this mRNA in activated hscs of ~24 h (8). In Swiss 3T3 fibroblasts grown on plastic there was no decay 12 h after addition of actinomycin D, while in cells grown in gel the half-life was ~12 h (Fig. 2). Prolonged exposure to actinomycin D proved to be toxic, so we could not quantitate the mRNA destabilization in these cells. Experiments with DRB also did not result in any measurable decay of 1(I) mRNA in cells grown on plastic. Nevertheless, it is clear that in rodent fibroblasts the turnover of collagen 1(I) mRNA is significantly modulated by the culture conditions employed. For primary human fibroblasts the half-life of collagen 1(I) mRNA was decreased from 4.4 to 2.1 h in cells grown on plastic and in gel, respectively (19).
Two cis-acting elements in collagen 1(I) mRNA regulate its metabolism; the 5' stem–loop (9) and the CP binding site in the 3'-UTR (8). The 5' stem–loop is a negative regulatory element, which prevents expression of reporter genes in quiescent hscs. In activated hscs a cytosolic protein factor(s) of unknown identity binds to the stem–loop and requires a 7mG cap for binding. This binding activity parallels mRNA expression (9). In Swiss 3T3 fibroblasts grown in gel the cytoplasmic 5' stem–loop binding activity was greatly reduced (Fig. 5). Concomitantly, the expression of endogenous collagen 1(I) mRNA (Fig. 1) was down-regulated. These results strongly suggest that the 5' stem–loop binding activity is required for high level expression in this system and is in agreement with the results using hscs. A reporter mRNA with a mutated stem–loop synthesized under the control of the SV40 promoter was expressed at a 2- to 4-fold higher level in cells grown in gel than on plastic (Fig. 3, lanes 3 and 4). Since experiments with a ß-galactosidase reporter gene utilizing a CMV promoter also gave increased expression in cells grown in gel (not shown), it is likely that the viral promoters are stimulated in cells grown in matrix. Such stimulation was, however, completely abrogated by placing the 5' stem–loop in the reporter mRNA (Fig. 3, lanes 1 and 2).
To provide further evidence for the role of the 5' stem–loop, we constructed hybrid mouse–human collagen 1(I) genes (Fig. 4). These genes allow synthesis of the full-size collagen 1(I) mRNA and analysis of the effects of the stem–loop mutation in its natural context. However, these genes contain only the first polyadenylation signal of the collagen 1(I) gene. Since collagen 1(I) mRNA exists as two species, 4.7 and 5.7 kb mRNA (42), the results obtained may not pertain to regulation of the 5.7 kb collagen 1(I) mRNA. We analyzed the stability of this hybrid mouse–human collagen 1(I) mRNA in NIH 3T3 cells grown in gel. When the 5' stem–loop was mutated, the hybrid mouse–human collagen 1(I) mRNA was more stable than when this stem–loop was intact, suggesting that in its natural context the 5' stem–loop is required for decay of collagen 1(I) mRNA (Fig. 4). The half-life of the hybrid mouse–human collagen 1(I) mRNA was ~6 h, which is shorter than that observed for endogenous collagen 1(I) mRNA in Swiss 3T3 cells (12 h; Fig. 2). As mentioned above, this may be due to different decay rates of the 4.7 and 5.7 kb collagen 1(I) mRNAs (6), which are both measured as endogenous collagen 1(I) mRNA, while only the 4.7 kb mRNA is represented by the hybrid mRNA. The difference may also result from the different cell type used, NIH 3T3 versus Swiss 3T3 fibroblasts, or be due to the transient transfection procedures.
The mechanism by which the stem–loop accelerates the decay of collagen 1(I) mRNA is not clear. Cytoplasmic factors which bind this structure seem to reverse its destabilizing effect. Here we have also described a nuclear protein that binds the stem–loop in a sequence-specific manner (Fig. 6). This activity seems to be different from the cytoplasmic activity. It can be detected only in nuclear extracts, it does not require the presence of a 7mG cap for binding in vitro and it has a different electrophoretic mobility in native gels. However, some subunits participating in this binding activity may be common in cytoplasmic and nuclear complexes. The nuclear binding inversely correlates with accumulation of collagen 1(I) mRNA (Fig. 6B), suggesting that it is a negative modulator of collagen 1(I) mRNA expression. It is possible that after synthesis, the collagen 5' stem–loop binds this nuclear factor, which may negatively affect transcriptional elongation (43,44), splicing or nuclear export. Upon export into the cytoplasm, the 5' stem–loop is recognized by the cytoplasmic binding protein(s). If this cytoplasmic protein(s) is absent, as in quiescent hscs (9), or reduced, as in fibroblasts grown in gel, 1(I) mRNA may be targeted for degradation. If it is present, the 1(I) mRNA may be stabilized and directed for translation, as in activated hscs (9) and fibroblasts grown on plastic. Collagen type I is a heterotrimer composed of two 1(I) chains and one 2(I) chain (1). Therefore, its assembly in endoplasmic reticulum would be more efficient, due to a higher local concentration of the chains, if both mRNAs are translated on a subset of ribosomes closely positioned on the rough endoplasmic reticulum. Cytoplasmic stem–loop binding activity may target collagen 1(I) mRNA to such a subset.
Binding of CP to the 3'-UTR of collagen 1(I) mRNA correlates with stabilization of this mRNA in hscs (8). In this work there was no difference in CP binding activity in cells grown on plastic or in gel (Fig. 5B). Perhaps, the difference in the culture conditions described here is not a sufficiently strong stimulus to change binding of this factor, as is differentiation of hscs (8). However, a role of CP in stimulating translation of some viral mRNAs has been documented (45,46) and preliminary results from our laboratory using the yeast two-hybrid system suggest that it can interact with poly(A) binding protein, a known stimulator of translation (47,48). Therefore, it is possible that CP further enhances translation of collagen 1(I) mRNA, and this is currently under investigation.
Based on the results presented in this paper it is likely that collagen 1(I) mRNA is regulated by a complex interaction with sequence-specific RNA binding proteins in both the nucleus and the cytoplasm. Modulation of these interactions is associated with changes in mRNA stability and accumulation.
|
FOOTNOTES |
|---|
* To whom correspondence should be addressed. Tel: +1 919 966 7885; Fax: +1 919 966 7468; Email: dab@med.unc.edu
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
-
1 Kivirikko,K.I. (1998) Matrix Biol., 16, 355–356.[Web of Science][Medline]
2 Slack,J.L., Liska,D.J. and Bornstein,P. (1993) Am. J. Med. Genet., 45, 140–151.[Web of Science][Medline]
3 Vuorio,E. and de Crombrugghe,B. (1990) Annu. Rev. Biochem., 59, 837–872.[Web of Science][Medline]
4 Focht,R.J. and Adams,S.L. (1984) Mol. Cell. Biol., 4, 1843–1852.
5 Panduro,A., Shalaby,F., Biempica,L. and Shafritz,D.A. (1988) Hepatology, 8, 259–266.[Web of Science][Medline]
6 Pentinnen,R.P., Kobayashi,S. and Bornstein,P. (1988) Proc. Natl Acad. Sci. USA, 85, 1105–1108.
7 Raghow,R., Postlethwaite,A.E., Keski-Oja,J., Moses,H.L. and Kang,A.H. (1987) J. Clin. Invest., 79, 1285–1288.
8 Stefanovic,B., Hellerbrand,C., Holcik,M., Briendl,M., Liebhaber,S.A. and Brenner,D.A. (1997) Mol. Cell. Biol., 17, 5201–5209.
9 Stefanovic,B., Hellerbrand,C. and Brenner,D.A. (1999) Mol. Cell. Biol., 19, 4334–4342.
10 Dhawan,J., Lichtler,A., Rowe,D. and Farmer,S.R. (1991) J. Biol. Chem., 266, 8470–8475.
11 Nehls,M.C., Rippe,R.A., Veloz,L. and Brenner,D.A. (1991) Mol. Cell. Biol., 11, 4065–4073.
12 Nehls,M.C., Grapilon,M.L. and Brenner,D.A. (1992) Mol. Cell. Biol., 11, 443–452.
13 Rippe,R.A., Almounajed,G. and Brenner,D.A. (1995) Gastroenterology, 22, 241–251.
14 Slack,J.L., Liska,D.J. and Bornstein,P. (1991) Mol. Cell. Biol., 11, 2066–2074.
15 Houglum,K., Buck,M., Alcorn,J., Contreras,S., Bornstein,P. and Chojkier,M. (1995) J. Clin. Invest., 96, 2269–2276.
16 Sokolov,B.P., Ala-Kokko,L., Dhulipala,R., Arita,M., Khillan,J.S. and Prockop,D.J. (1995) J. Biol. Chem., 270, 9622–9629.
17 Rossert,J., Eberspaecher,H. and de Crombrugghe,B. (1995) J. Cell Biol., 129, 1421–1432.
18 Salimi-Tari,P., Cheung,M., Safar,C., Tracy,J., Tran,I., Harbers,K. and Breindl,M. (1997) Genes Dev., 198, 61–72.
19 Eckes,B., Mauch,C., Huppe,G. and Krieg,T. (1996) FEBS Lett., 318, 129–133.
20 Eckes,B., Mauch,C., Huppe,G. and Krieg,T. (1996) Biochem. J., 315, 549–554.
21 Wang,X., Kiledjian,M., Weiss,I.M. and Liebhaber,S.A. (1995) Mol. Cell. Biol., 15, 1769–1777.
22 Kiledjian,M., Wang,X. and Liebhaber,S.A. (1995) EMBO J., 14, 4357–4364.[Web of Science][Medline]
23 Holcik,M. and Liebhaber,S.A. (1997) Proc. Natl Acad. Sci. USA, 94, 2410–2414.
24 Paulding,W. and Czyzyk-Kyzeska,M. (1999) J. Biol. Chem., 274, 2532–38.
25 Yamada,Y., Mudryj,M. and de Crombrugghe,B. (1983) J. Biol. Chem., 258, 14914–14919.
26 Nakatsukasa,H., Nagy,P., Evarts,R.P., Chu-Chieh,H., Marsden,E. and Thorgeirsson,S.S. (1990) J. Clin. Invest., 85, 1833–1843.
27 Masuda,H., Fukumoto,M., Hirayoshi,K. and Nagata,K. (1994) J. Clin. Invest., 94, 2481–2488.
28 Milani,S., Herbst,H., Schuppan,D., Kim,K.Y., Riecken,E.O. and Stein,H. (1990) Gastroenterology, 98, 175–184.[Web of Science][Medline]
29 Schupan,D. (1990) Semin. Liver Dis., 10, 1–10.[Web of Science][Medline]
30 Maher,J.J., Zia,S. and Tzagarakis,C. (1994) Alcohol Clin. Exp. Res., 18, 403–409.[Web of Science][Medline]
31 Contard,P., Jacobs,L.I., Perlish,J. and Fleischmajer,R. (1993) Cell Tissue Res., 273, 571–575.[Web of Science][Medline]
32 Sato,M., Ishikawa,O. and Miyachi,Y. (1998) Br. J. Dermatol., 138, 938–943.[Web of Science][Medline]
33 Mauch,C., Hatamochi,A., Scharffetter,K. and Krieg,T. (1988) Exp. Cell Res., 178, 493–503.[Web of Science][Medline]
34 Ishikawa,O., Kondo,A., Okada,K., Miyachi,Y. and Furumura,M. (1997) Br. J. Dermatol., 136, 6–11.[Web of Science][Medline]
35 Friedman,S.L., Roll,F.J., Boyles,J., Arenson,D.M. and Bissell,D.M. (1989) Proc. Natl Acad. Sci. USA, 264, 10756–10762.
36 Dignam,J.D., Lebovitz,R.M. and Roeder,R.G. (1983) Nucleic Acids Res., 11, 1475–1489.
37 Haghighat,A. and Sonenberg,N. (1997) J. Biol. Chem., 272, 21677–21680.
38 Wang,Z., Whitfield,M., Ingledue,T.I., Dominski,Z. and Marzluff,W.F. (1996) Genes Dev., 10, 3028–3040.
39 Kao,S., Calman,A., Luciw,P.A. and Peterlin,B. (1987) Nature, 330, 489–493.[Medline]
40 Hamalainen,L., Oikarinen,J. and Kivirikko,K.I. (1985) J. Biol. Chem., 260, 720–725.
41 Slack,J.L., Parker,M.I., Robinson,V.R. and Bornstein,P. (1992) Mol. Cell. Biol., 12, 4714–4723.
42 Mooslehner,K. and Harbers,K. (1988) Nucleic Acids Res., 16, 773–778.
43 Krumm,A., Meulia,T. and Groudine,M. (1993) Bioessays, 15, 659–665.[Web of Science][Medline]
44 Krumm,A., Hickey,L.B. and Groudine,M. (1995) Genes Dev., 9, 559–572.
45 Niepmann,M., Petersen,A., Meyer,K. and Beck,E. (1997) J. Virol., 71, 8330–8339.
46 Gamarnik,A.V. and Andino,R. (1997) RNA, 3, 882–892.[Abstract]
47 Gallis,B. (1991) Genes Dev., 5, 2108–2116.
48 Coller,J., Gray,N.K. and Wickens,M. (1998) Genes Dev., 12, 3226–3235.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Jiang and B. Stefanovic Homeobox Gene Prx1 Is Expressed in Activated Hepatic Stellate Cells and Transactivates Collagen {alpha}1(I) Promoter Exp Biol Med, March 1, 2008; 233(3): 286 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Lindquist, C. J. Parsons, B. Stefanovic, and D. A. Brenner Regulation of {alpha}1(I) Collagen Messenger RNA Decay by Interactions with {alpha}CP at the 3'-Untranslated Region J. Biol. Chem., May 28, 2004; 279(22): 23822 - 23829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stefanovic and D. A. Brenner 5' Stem-Loop of Collagen alpha 1(I) mRNA Inhibits Translation in Vitro but Is Required for Triple Helical Collagen Synthesis in Vivo J. Biol. Chem., January 3, 2003; 278(2): 927 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stefanovic, B. Schnabl, and D. A. Brenner Inhibition of Collagen alpha 1(I) Expression by the 5' Stem-Loop as a Molecular Decoy J. Biol. Chem., May 10, 2002; 277(20): 18229 - 18237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nieto, S. L. Friedman, and A. I. Cederbaum Cytochrome P450 2E1-derived Reactive Oxygen Species Mediate Paracrine Stimulation of Collagen I Protein Synthesis by Hepatic Stellate Cells J. Biol. Chem., March 15, 2002; 277(12): 9853 - 9864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Ricupero, C. F. Poliks, D. C. Rishikof, K. A. Cuttle, P.-P. Kuang, and R. H. Goldstein Phosphatidylinositol 3-kinase-dependent stabilization of {alpha}1(I) collagen mRNA in human lung fibroblasts Am J Physiol Cell Physiol, July 1, 2001; 281(1): C99 - C105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Lindquist, S. G. Kauschke, B. Stefanovic, E. R. Burchardt, and D. A. Brenner Characterization of the interaction between {alpha}CP2 and the 3'-untranslated region of collagen {alpha}1(I) mRNA Nucleic Acids Res., November 1, 2000; 28(21): 4306 - 4316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Lindquist, W. F. Marzluff, and B. Stefanovic Fibrogenesis: III. Posttranscriptional regulation of type I collagen Am J Physiol Gastrointest Liver Physiol, September 1, 2000; 279(3): G471 - G476. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||